Table of Content

1 13-Valent Pneumococcal Conjugate Vaccine Market Overview
1.1 Product Overview and Scope of 13-Valent Pneumococcal Conjugate Vaccine
1.2 13-Valent Pneumococcal Conjugate Vaccine Segment by Type
1.2.1 Global 13-Valent Pneumococcal Conjugate Vaccine Market Value Comparison by Type (2024-2034)
1.2.2 Vials
1.2.3 Pre-filled
1.3 13-Valent Pneumococcal Conjugate Vaccine Segment by Application
1.3.1 Global 13-Valent Pneumococcal Conjugate Vaccine Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 CDC
1.4 Global 13-Valent Pneumococcal Conjugate Vaccine Market Size Estimates and Forecasts
1.4.1 Global 13-Valent Pneumococcal Conjugate Vaccine Revenue 2018-2029
1.4.2 Global 13-Valent Pneumococcal Conjugate Vaccine Sales 2018-2029
1.4.3 Global 13-Valent Pneumococcal Conjugate Vaccine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 13-Valent Pneumococcal Conjugate Vaccine Market Competition by Manufacturers
2.1 Global 13-Valent Pneumococcal Conjugate Vaccine Sales Market Share by Manufacturers (2018-2024)
2.2 Global 13-Valent Pneumococcal Conjugate Vaccine Revenue Market Share by Manufacturers (2018-2024)
2.3 Global 13-Valent Pneumococcal Conjugate Vaccine Average Price by Manufacturers (2018-2024)
2.4 Global 13-Valent Pneumococcal Conjugate Vaccine Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of 13-Valent Pneumococcal Conjugate Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of 13-Valent Pneumococcal Conjugate Vaccine, Product Type & Application
2.7 13-Valent Pneumococcal Conjugate Vaccine Market Competitive Situation and Trends
2.7.1 13-Valent Pneumococcal Conjugate Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest 13-Valent Pneumococcal Conjugate Vaccine Players Market Share by Revenue
2.7.3 Global 13-Valent Pneumococcal Conjugate Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 13-Valent Pneumococcal Conjugate Vaccine Retrospective Market Scenario by Region
3.1 Global 13-Valent Pneumococcal Conjugate Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global 13-Valent Pneumococcal Conjugate Vaccine Global 13-Valent Pneumococcal Conjugate Vaccine Sales by Region: 2018-2029
3.2.1 Global 13-Valent Pneumococcal Conjugate Vaccine Sales by Region: 2018-2024
3.2.2 Global 13-Valent Pneumococcal Conjugate Vaccine Sales by Region: 2024-2029
3.3 Global 13-Valent Pneumococcal Conjugate Vaccine Global 13-Valent Pneumococcal Conjugate Vaccine Revenue by Region: 2018-2029
3.3.1 Global 13-Valent Pneumococcal Conjugate Vaccine Revenue by Region: 2018-2024
3.3.2 Global 13-Valent Pneumococcal Conjugate Vaccine Revenue by Region: 2024-2029
3.4 North America 13-Valent Pneumococcal Conjugate Vaccine Market Facts & Figures by Country
3.4.1 North America 13-Valent Pneumococcal Conjugate Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America 13-Valent Pneumococcal Conjugate Vaccine Sales by Country (2018-2029)
3.4.3 North America 13-Valent Pneumococcal Conjugate Vaccine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe 13-Valent Pneumococcal Conjugate Vaccine Market Facts & Figures by Country
3.5.1 Europe 13-Valent Pneumococcal Conjugate Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe 13-Valent Pneumococcal Conjugate Vaccine Sales by Country (2018-2029)
3.5.3 Europe 13-Valent Pneumococcal Conjugate Vaccine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific 13-Valent Pneumococcal Conjugate Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific 13-Valent Pneumococcal Conjugate Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific 13-Valent Pneumococcal Conjugate Vaccine Sales by Country (2018-2029)
3.6.3 Asia Pacific 13-Valent Pneumococcal Conjugate Vaccine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America 13-Valent Pneumococcal Conjugate Vaccine Market Facts & Figures by Country
3.7.1 Latin America 13-Valent Pneumococcal Conjugate Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America 13-Valent Pneumococcal Conjugate Vaccine Sales by Country (2018-2029)
3.7.3 Latin America 13-Valent Pneumococcal Conjugate Vaccine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa 13-Valent Pneumococcal Conjugate Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa 13-Valent Pneumococcal Conjugate Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa 13-Valent Pneumococcal Conjugate Vaccine Sales by Country (2018-2029)
3.8.3 Middle East and Africa 13-Valent Pneumococcal Conjugate Vaccine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global 13-Valent Pneumococcal Conjugate Vaccine Sales by Type (2018-2029)
4.1.1 Global 13-Valent Pneumococcal Conjugate Vaccine Sales by Type (2018-2024)
4.1.2 Global 13-Valent Pneumococcal Conjugate Vaccine Sales by Type (2024-2029)
4.1.3 Global 13-Valent Pneumococcal Conjugate Vaccine Sales Market Share by Type (2018-2029)
4.2 Global 13-Valent Pneumococcal Conjugate Vaccine Revenue by Type (2018-2029)
4.2.1 Global 13-Valent Pneumococcal Conjugate Vaccine Revenue by Type (2018-2024)
4.2.2 Global 13-Valent Pneumococcal Conjugate Vaccine Revenue by Type (2024-2029)
4.2.3 Global 13-Valent Pneumococcal Conjugate Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global 13-Valent Pneumococcal Conjugate Vaccine Price by Type (2018-2029)
5 Segment by Application
5.1 Global 13-Valent Pneumococcal Conjugate Vaccine Sales by Application (2018-2029)
5.1.1 Global 13-Valent Pneumococcal Conjugate Vaccine Sales by Application (2018-2024)
5.1.2 Global 13-Valent Pneumococcal Conjugate Vaccine Sales by Application (2024-2029)
5.1.3 Global 13-Valent Pneumococcal Conjugate Vaccine Sales Market Share by Application (2018-2029)
5.2 Global 13-Valent Pneumococcal Conjugate Vaccine Revenue by Application (2018-2029)
5.2.1 Global 13-Valent Pneumococcal Conjugate Vaccine Revenue by Application (2018-2024)
5.2.2 Global 13-Valent Pneumococcal Conjugate Vaccine Revenue by Application (2024-2029)
5.2.3 Global 13-Valent Pneumococcal Conjugate Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global 13-Valent Pneumococcal Conjugate Vaccine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer 13-Valent Pneumococcal Conjugate Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Pfizer 13-Valent Pneumococcal Conjugate Vaccine Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Kangtai
6.2.1 Kangtai Corporation Information
6.2.2 Kangtai Description and Business Overview
6.2.3 Kangtai 13-Valent Pneumococcal Conjugate Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Kangtai 13-Valent Pneumococcal Conjugate Vaccine Product Portfolio
6.2.5 Kangtai Recent Developments/Updates
6.3 Walvax Biotechnology
6.3.1 Walvax Biotechnology Corporation Information
6.3.2 Walvax Biotechnology Description and Business Overview
6.3.3 Walvax Biotechnology 13-Valent Pneumococcal Conjugate Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Walvax Biotechnology 13-Valent Pneumococcal Conjugate Vaccine Product Portfolio
6.3.5 Walvax Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 13-Valent Pneumococcal Conjugate Vaccine Industry Chain Analysis
7.2 13-Valent Pneumococcal Conjugate Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 13-Valent Pneumococcal Conjugate Vaccine Production Mode & Process
7.4 13-Valent Pneumococcal Conjugate Vaccine Sales and Marketing
7.4.1 13-Valent Pneumococcal Conjugate Vaccine Sales Channels
7.4.2 13-Valent Pneumococcal Conjugate Vaccine Distributors
7.5 13-Valent Pneumococcal Conjugate Vaccine Customers
8 13-Valent Pneumococcal Conjugate Vaccine Market Dynamics
8.1 13-Valent Pneumococcal Conjugate Vaccine Industry Trends
8.2 13-Valent Pneumococcal Conjugate Vaccine Market Drivers
8.3 13-Valent Pneumococcal Conjugate Vaccine Market Challenges
8.4 13-Valent Pneumococcal Conjugate Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global 13-Valent Pneumococcal Conjugate Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global 13-Valent Pneumococcal Conjugate Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global 13-Valent Pneumococcal Conjugate Vaccine Market Competitive Situation by Manufacturers in 2022
Table 4. Global 13-Valent Pneumococcal Conjugate Vaccine Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global 13-Valent Pneumococcal Conjugate Vaccine Sales Market Share by Manufacturers (2018-2024)
Table 6. Global 13-Valent Pneumococcal Conjugate Vaccine Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global 13-Valent Pneumococcal Conjugate Vaccine Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market 13-Valent Pneumococcal Conjugate Vaccine Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of 13-Valent Pneumococcal Conjugate Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of 13-Valent Pneumococcal Conjugate Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of 13-Valent Pneumococcal Conjugate Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of 13-Valent Pneumococcal Conjugate Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global 13-Valent Pneumococcal Conjugate Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 13-Valent Pneumococcal Conjugate Vaccine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global 13-Valent Pneumococcal Conjugate Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global 13-Valent Pneumococcal Conjugate Vaccine Sales by Region (2018-2024) & (K Units)
Table 18. Global 13-Valent Pneumococcal Conjugate Vaccine Sales Market Share by Region (2018-2024)
Table 19. Global 13-Valent Pneumococcal Conjugate Vaccine Sales by Region (2024-2029) & (K Units)
Table 20. Global 13-Valent Pneumococcal Conjugate Vaccine Sales Market Share by Region (2024-2029)
Table 21. Global 13-Valent Pneumococcal Conjugate Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global 13-Valent Pneumococcal Conjugate Vaccine Revenue Market Share by Region (2018-2024)
Table 23. Global 13-Valent Pneumococcal Conjugate Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global 13-Valent Pneumococcal Conjugate Vaccine Revenue Market Share by Region (2024-2029)
Table 25. North America 13-Valent Pneumococcal Conjugate Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America 13-Valent Pneumococcal Conjugate Vaccine Sales by Country (2018-2024) & (K Units)
Table 27. North America 13-Valent Pneumococcal Conjugate Vaccine Sales by Country (2024-2029) & (K Units)
Table 28. North America 13-Valent Pneumococcal Conjugate Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America 13-Valent Pneumococcal Conjugate Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe 13-Valent Pneumococcal Conjugate Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe 13-Valent Pneumococcal Conjugate Vaccine Sales by Country (2018-2024) & (K Units)
Table 32. Europe 13-Valent Pneumococcal Conjugate Vaccine Sales by Country (2024-2029) & (K Units)
Table 33. Europe 13-Valent Pneumococcal Conjugate Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe 13-Valent Pneumococcal Conjugate Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific 13-Valent Pneumococcal Conjugate Vaccine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific 13-Valent Pneumococcal Conjugate Vaccine Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific 13-Valent Pneumococcal Conjugate Vaccine Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific 13-Valent Pneumococcal Conjugate Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific 13-Valent Pneumococcal Conjugate Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America 13-Valent Pneumococcal Conjugate Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America 13-Valent Pneumococcal Conjugate Vaccine Sales by Country (2018-2024) & (K Units)
Table 42. Latin America 13-Valent Pneumococcal Conjugate Vaccine Sales by Country (2024-2029) & (K Units)
Table 43. Latin America 13-Valent Pneumococcal Conjugate Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America 13-Valent Pneumococcal Conjugate Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa 13-Valent Pneumococcal Conjugate Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa 13-Valent Pneumococcal Conjugate Vaccine Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa 13-Valent Pneumococcal Conjugate Vaccine Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa 13-Valent Pneumococcal Conjugate Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa 13-Valent Pneumococcal Conjugate Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global 13-Valent Pneumococcal Conjugate Vaccine Sales (K Units) by Type (2018-2024)
Table 51. Global 13-Valent Pneumococcal Conjugate Vaccine Sales (K Units) by Type (2024-2029)
Table 52. Global 13-Valent Pneumococcal Conjugate Vaccine Sales Market Share by Type (2018-2024)
Table 53. Global 13-Valent Pneumococcal Conjugate Vaccine Sales Market Share by Type (2024-2029)
Table 54. Global 13-Valent Pneumococcal Conjugate Vaccine Revenue (US$ Million) by Type (2018-2024)
Table 55. Global 13-Valent Pneumococcal Conjugate Vaccine Revenue (US$ Million) by Type (2024-2029)
Table 56. Global 13-Valent Pneumococcal Conjugate Vaccine Revenue Market Share by Type (2018-2024)
Table 57. Global 13-Valent Pneumococcal Conjugate Vaccine Revenue Market Share by Type (2024-2029)
Table 58. Global 13-Valent Pneumococcal Conjugate Vaccine Price (US$/Unit) by Type (2018-2024)
Table 59. Global 13-Valent Pneumococcal Conjugate Vaccine Price (US$/Unit) by Type (2024-2029)
Table 60. Global 13-Valent Pneumococcal Conjugate Vaccine Sales (K Units) by Application (2018-2024)
Table 61. Global 13-Valent Pneumococcal Conjugate Vaccine Sales (K Units) by Application (2024-2029)
Table 62. Global 13-Valent Pneumococcal Conjugate Vaccine Sales Market Share by Application (2018-2024)
Table 63. Global 13-Valent Pneumococcal Conjugate Vaccine Sales Market Share by Application (2024-2029)
Table 64. Global 13-Valent Pneumococcal Conjugate Vaccine Revenue (US$ Million) by Application (2018-2024)
Table 65. Global 13-Valent Pneumococcal Conjugate Vaccine Revenue (US$ Million) by Application (2024-2029)
Table 66. Global 13-Valent Pneumococcal Conjugate Vaccine Revenue Market Share by Application (2018-2024)
Table 67. Global 13-Valent Pneumococcal Conjugate Vaccine Revenue Market Share by Application (2024-2029)
Table 68. Global 13-Valent Pneumococcal Conjugate Vaccine Price (US$/Unit) by Application (2018-2024)
Table 69. Global 13-Valent Pneumococcal Conjugate Vaccine Price (US$/Unit) by Application (2024-2029)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer 13-Valent Pneumococcal Conjugate Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Pfizer 13-Valent Pneumococcal Conjugate Vaccine Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Kangtai Corporation Information
Table 76. Kangtai Description and Business Overview
Table 77. Kangtai 13-Valent Pneumococcal Conjugate Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Kangtai 13-Valent Pneumococcal Conjugate Vaccine Product
Table 79. Kangtai Recent Developments/Updates
Table 80. Walvax Biotechnology Corporation Information
Table 81. Walvax Biotechnology Description and Business Overview
Table 82. Walvax Biotechnology 13-Valent Pneumococcal Conjugate Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Walvax Biotechnology 13-Valent Pneumococcal Conjugate Vaccine Product
Table 84. Walvax Biotechnology Recent Developments/Updates
Table 85. Key Raw Materials Lists
Table 86. Raw Materials Key Suppliers Lists
Table 87. 13-Valent Pneumococcal Conjugate Vaccine Distributors List
Table 88. 13-Valent Pneumococcal Conjugate Vaccine Customers List
Table 89. 13-Valent Pneumococcal Conjugate Vaccine Market Trends
Table 90. 13-Valent Pneumococcal Conjugate Vaccine Market Drivers
Table 91. 13-Valent Pneumococcal Conjugate Vaccine Market Challenges
Table 92. 13-Valent Pneumococcal Conjugate Vaccine Market Restraints
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of 13-Valent Pneumococcal Conjugate Vaccine
Figure 2. Global 13-Valent Pneumococcal Conjugate Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global 13-Valent Pneumococcal Conjugate Vaccine Market Share by Type in 2022 & 2029
Figure 4. Vials Product Picture
Figure 5. Pre-filled Product Picture
Figure 6. Global 13-Valent Pneumococcal Conjugate Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global 13-Valent Pneumococcal Conjugate Vaccine Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Clinic
Figure 10. CDC
Figure 11. Global 13-Valent Pneumococcal Conjugate Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global 13-Valent Pneumococcal Conjugate Vaccine Market Size (2018-2029) & (US$ Million)
Figure 13. Global 13-Valent Pneumococcal Conjugate Vaccine Sales (2018-2029) & (K Units)
Figure 14. Global 13-Valent Pneumococcal Conjugate Vaccine Average Price (US$/Unit) & (2018-2029)
Figure 15. 13-Valent Pneumococcal Conjugate Vaccine Report Years Considered
Figure 16. 13-Valent Pneumococcal Conjugate Vaccine Sales Share by Manufacturers in 2022
Figure 17. Global 13-Valent Pneumococcal Conjugate Vaccine Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest 13-Valent Pneumococcal Conjugate Vaccine Players: Market Share by Revenue in 2022
Figure 19. 13-Valent Pneumococcal Conjugate Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global 13-Valent Pneumococcal Conjugate Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America 13-Valent Pneumococcal Conjugate Vaccine Sales Market Share by Country (2018-2029)
Figure 22. North America 13-Valent Pneumococcal Conjugate Vaccine Revenue Market Share by Country (2018-2029)
Figure 23. United States 13-Valent Pneumococcal Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada 13-Valent Pneumococcal Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe 13-Valent Pneumococcal Conjugate Vaccine Sales Market Share by Country (2018-2029)
Figure 26. Europe 13-Valent Pneumococcal Conjugate Vaccine Revenue Market Share by Country (2018-2029)
Figure 27. Germany 13-Valent Pneumococcal Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France 13-Valent Pneumococcal Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. 13-Valent Pneumococcal Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy 13-Valent Pneumococcal Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia 13-Valent Pneumococcal Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific 13-Valent Pneumococcal Conjugate Vaccine Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific 13-Valent Pneumococcal Conjugate Vaccine Revenue Market Share by Region (2018-2029)
Figure 34. China 13-Valent Pneumococcal Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan 13-Valent Pneumococcal Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea 13-Valent Pneumococcal Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India 13-Valent Pneumococcal Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia 13-Valent Pneumococcal Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan 13-Valent Pneumococcal Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Southeast Asia 13-Valent Pneumococcal Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Latin America 13-Valent Pneumococcal Conjugate Vaccine Sales Market Share by Country (2018-2029)
Figure 42. Latin America 13-Valent Pneumococcal Conjugate Vaccine Revenue Market Share by Country (2018-2029)
Figure 43. Mexico 13-Valent Pneumococcal Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Brazil 13-Valent Pneumococcal Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Argentina 13-Valent Pneumococcal Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Colombia 13-Valent Pneumococcal Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa 13-Valent Pneumococcal Conjugate Vaccine Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa 13-Valent Pneumococcal Conjugate Vaccine Revenue Market Share by Country (2018-2029)
Figure 49. Turkey 13-Valent Pneumococcal Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia 13-Valent Pneumococcal Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE 13-Valent Pneumococcal Conjugate Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of 13-Valent Pneumococcal Conjugate Vaccine by Type (2018-2029)
Figure 53. Global Revenue Market Share of 13-Valent Pneumococcal Conjugate Vaccine by Type (2018-2029)
Figure 54. Global 13-Valent Pneumococcal Conjugate Vaccine Price (US$/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of 13-Valent Pneumococcal Conjugate Vaccine by Application (2018-2029)
Figure 56. Global Revenue Market Share of 13-Valent Pneumococcal Conjugate Vaccine by Application (2018-2029)
Figure 57. Global 13-Valent Pneumococcal Conjugate Vaccine Price (US$/Unit) by Application (2018-2029)
Figure 58. 13-Valent Pneumococcal Conjugate Vaccine Value Chain
Figure 59. 13-Valent Pneumococcal Conjugate Vaccine Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed